canonical: https://aviantestpro.com/knowledge/disease-testing/avian-polyomavirus

Avian Polyomavirus (APV) Testing¶

Background¶

Avian Polyomavirus (APV) — also known as Budgerigar Fledgling Disease Virus — causes acute disease in young psittacines, particularly budgerigars, with high mortality in nestlings and fledglings. Adult birds can be asymptomatic carriers and shed virus intermittently, making diagnostic detection essential for breeding program management.

APV is a non-enveloped, double-stranded DNA virus of the family Polyomaviridae. The VP1 major capsid protein is highly conserved and serves as the primary target for PCR-based diagnostics. APV infection can present as:

Peracute form: Sudden death with no premonitory signs (common in fledglings 2–8 weeks old)
Acute form: Ascites, abdominal distension, subcutaneous hemorrhages, feather abnormalities
Subclinical form: Asymptomatic carrier state in adult birds with intermittent fecal shedding

SENO Test Characteristics¶

Parameter	Value
Target Gene	VP1 (major capsid protein)
Assay Type	Conventional PCR (nested option available)
Amplicon Size	~550 bp (diagnostic) / ~320 bp (nested)
LOD (estimated)	~100 copies/reaction
Specificity	No cross-reactivity with BFDV, Pigeon circovirus, or Adenovirus
Controls	Positive (APV plasmid) + NTC + extraction blank
Species Validated	Budgerigar, Lovebird, Parrotlet, Macaw, African Grey, Conure
Turnaround	2–3 working days (standard)
Rush turnaround	24 hours (by arrangement)

Detailed PCR Protocol¶

Step 1 — DNA Extraction¶

Parameter	Detail
Extraction method	Magnetic bead-based or spin-column
Starting material	200 µL swab transport medium or 25 mg tissue
Elution volume	50–100 µL
Internal control	Exogenous DNA control co-extracted to monitor inhibition
Quality check	Spectrophotometric quantification (A260/A280 > 1.8)

Step 2 — Primary PCR (VP1-550)¶

Component	Volume (µL)
2× PCR Master Mix	12.5
Forward primer (10 µM)	1.0
Reverse primer (10 µM)	1.0
Template DNA	2.0
Nuclease-free water	8.5
Total	25.0

Cycling Step	Temperature	Time	Cycles
Initial denaturation	95 °C	3 min	1
Denaturation	95 °C	30 s	35
Annealing	55 °C	30 s	35
Extension	72 °C	45 s	35
Final extension	72 °C	5 min	1
Hold	4 °C	∞	1

Step 3 — Nested PCR (VP1-320, optional)¶

Component	Volume (µL)
2× PCR Master Mix	12.5
Nested forward primer (10 µM)	1.0
Nested reverse primer (10 µM)	1.0
Template (primary PCR product, 1:10 dilution)	2.0
Nuclease-free water	8.5
Total	25.0

Cycling Step	Temperature	Time	Cycles
Initial denaturation	95 °C	3 min	1
Denaturation	95 °C	30 s	30
Annealing	55 °C	30 s	30
Extension	72 °C	30 s	30
Final extension	72 °C	5 min	1
Hold	4 °C	∞	1

Step 4 — Gel Electrophoresis¶

Parameter	Detail
Gel	1.5% agarose in 1× TAE
Stain	GelRed or ethidium bromide
Marker	100 bp DNA ladder
Expected band	550 bp (primary) / 320 bp (nested)
Visualization	UV transilluminator or gel documentation system

Clinical Signs That Warrant Testing¶

Age Group	Key Signs	Differential
Fledglings (2–8 weeks)	Sudden death, ascites, abdominal distension, subcutaneous hemorrhage	PBFD, bacterial infection, nutritional deficiency
Nestlings	Feather abnormalities, delayed fledging, stunted growth	PBFD, malnutrition, circovirus
Adults	Usually asymptomatic; subclinical carriers	Carrier status; risk to young birds

When to Test¶

Scenario	Recommended Action	Urgency
Recent fledgling death in aviary	Test surviving nestlings and parents	Immediate
New bird entering breeding collection	Pre-introduction screening	Before quarantine release
Imported psittacine (any age)	Quarantine day 14 test	Routine
Known APV outbreak in facility	Test all young birds; consider testing adults	Immediate
Breeding pair with history of fledgling mortality	Screen both parents before next breeding	Before breeding season
Post-mortem from suspected APV case	Fresh liver, kidney, or spleen tissue	As soon as possible

Result Interpretation¶

Result	Band Pattern	Interpretation	Action
Positive	Clear band at 550 bp (or 320 bp nested)	APV DNA detected	See management below
Negative	No band; positive control works	No detectable APV	If suspicion remains, retest in 2–3 weeks
Weak positive	Faint band	Low viral load	Retest on fresh sample; consider early infection or carrier
Indeterminate	Band at unexpected size	Possible non-specific amplification	Sequence to confirm; report as inconclusive until resolved
Inhibited	No band in sample + IC (if used) fails	PCR inhibition present	Re-extract and retest with diluted template

Disease Progression and Pathology¶

Stage	Timeframe (young birds)	Clinical Findings	Viral Shedding
Incubation	3–7 days post-exposure	No signs	Low
Early viremia	7–10 days	Lethargy, reduced appetite	Moderate
Clinical peak	10–14 days	Ascites, dyspnea, abdominal distension, hemorrhages	High
Death or recovery	14–21 days	High mortality (50–100% in nestlings)	Declining
Carrier state (survivors / adults)	Persistent	None	Intermittent

Carrier Management¶

Finding	Recommendation	Follow-up
Positive — symptomatic	Supportive care (fluids, nutrition, warmth); isolate; control secondary infections with broad-spectrum antibiotics	Retest 30 days post-recovery
Positive — asymptomatic carrier (adult)	Do not breed. Isolate from young birds; retest in 3 months	If still positive after 3 months, permanent carrier status likely
Positive — nestling	Isolate from other young birds; high mortality expected	Supportive care; if survived, retest at 6 months
Positive — imported bird	Extend quarantine to 60 days; retest at day 30 and day 60	Two consecutive negatives required for release
Negative — if clinical suspicion remains	Retest in 2–3 weeks	Consider differentials (PBFD, bacterial infection, adenovirus)
Negative — pre-breeding	No restriction; retest before next season if exposure risk exists	Routine annual screening recommended

Prevalence and Epidemiology¶

Region	Reported Prevalence in Psittacines	Source
China — pet birds	8–15% (asymptomatic carriers)	SENO internal data, 2024
China — breeding facilities	20–35% when history of fledgling mortality	SENO internal data, 2024
Europe — aviaries	10–25%	Published literature
North America — captive psittacines	5–20%	Published literature
Australia — wild psittacines	< 5%	Published literature

Co-infection Considerations¶

Co-Pathogen	Clinical Impact	Testing Recommendation
PBFD (BFDV)	Worsened feather and beak lesions; synergistic immunosuppression	Include PBFD qPCR in the same submission
Chlamydia psittaci	Exacerbated respiratory signs in young birds	Consider chlamydial PCR
E. coli / Klebsiella	Secondary bacterial infection common in APV-weakened birds	Add bacterial culture if clinical signs persist
Candida / Aspergillus	Fungal overgrowth after antibiotic use; immunosuppression	Oral swab culture if yeast/hyphae seen

Prevention and Biosecurity¶

Measure	Recommendation	Evidence Level
Quarantine new birds	Minimum 30 days; test at day 14	Strong
Separate age groups	House fledglings away from adults	Moderate
Disinfect cages	Use 0.5% sodium hypochlorite or accelerated hydrogen peroxide	Strong (non-enveloped virus)
Limit visitors	Restrict aviary access during breeding season	Moderate
Breeder screening	Test all breeding birds annually before pairing	Strong for affected facilities
In-contact bird testing	Test all birds in the same airspace as a confirmed case	Strong

Frequently Asked Questions¶

Question	Answer
Can APV infect non-psittacine birds?	Yes — APV has been reported in finches, canaries, and some raptors, though at lower prevalence.
Do pigeons get polyomavirus?	Pigeons have their own polyomavirus (PiHV, included in SENO Pigeon Disease Panel), caused by Avian polyomavirus species.
Is there a vaccine for APV?	No commercially available vaccine in China. Some experimental vaccines exist but are not widely validated.
How long does APV persist in the environment?	Non-enveloped virus — resistant; persists weeks to months in organic material. Disinfection is critical.
Can a carrier adult ever clear the virus?	Some adults may clear over months to years, but most remain lifelong carriers.

SENO is committed to providing accurate, timely, and trusted molecular diagnostics for the global avian community. For questions about test selection, interpretation, or research collaboration, contact our technical team.